Skip to content

4Accepted Oct 9, 6:36 PM ET

Astera Labs: director Stefan A Dyckerhoff sold 12,499 shares

ALABAstera Labs, Inc.

Accepted (ET)

6:36 PM

Oct 9, 2026

Filed

Oct 9, 2026

Documents

1

Size

15.3 KB

Summary

Astera Labs: director Stefan A Dyckerhoff sold 12,499 shares

Updated

What happened

  • The filing shows Stefan A Dyckerhoff, a director of Astera Labs, sold 12,499 shares in open-market transactions on Oct 7, 2026, at $376.06 per share for a total of $4,700,374. The filing also shows a grant of 68 restricted stock units (RSUs) on Oct 1, 2026, reported at $311.57 per share for a total of $21,187.

Key details

  • Transaction dates and prices:
    • Oct 1, 2026: Award/grant of 68 RSUs at $311.57, total $21,187 (code A).
    • Oct 7, 2026: Sale of 3,505 shares at $376.06, total $1,318,090 (code S).
    • Oct 7, 2026: Sale of 8,333 shares at $376.06, total $3,133,708 (code S).
    • Oct 7, 2026: Sale of 661 shares at $376.06, total $248,576 (code S).
  • Shares owned after the transaction: not reported in the information provided from the filing.
  • Footnotes that matter:
    • F1: The 68 RSUs were granted under the 2024 Stock Option and Incentive Plan in lieu of quarterly non-employee director cash retainer fees; 100% of those RSUs vest on the three-month anniversary of the Vesting Commencement Date of Aug 15, 2026. The reporting person shares pecuniary interest in these shares and disclaims beneficial ownership except for that pecuniary interest.
    • F3: The Oct 7, 2026 sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on Dec 1, 2025.
  • Filing date: the Form 4 was filed on Oct 9, 2026.

Why it may matter

  • The filing records an RSU award (grant) and open-market sales executed under a Rule 10b5-1 trading plan. The filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing